Previous Trainees

  • Position Dates: 
    Friday, 1 January, 2016 to Wednesday, 30 May, 2018
    Position: 
    SANTHE Post-doctoral Trainee, Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya

    Hassan worked with the HIV/STI studies group based at the KEMRI/Wellcome Trust Research Programme in Kilifi, Kenya with an interest in understanding HIV-host interactions and their contribution to disease pathogenesis.

  • Position Dates: 
    Monday, 1 May, 2017 to Monday, 30 April, 2018
    Position: 
    SANTHE Post-doctoral Trainee, University of KwaZulu-Natal (UKZN), Durban, South Africa
  • Position Dates: 
    Sunday, 1 May, 2016 to Monday, 30 April, 2018
    Position: 
    SANTHE Post-doctoral Trainee, University of KwaZulu-Natal (UKZN), Durban, South Africa

    Passo’s study focussed on computationally reconstructing as accurately as possible, the early spatio-temporal history (as in pre 1930s) of the HIV-1M epidemic.

  • Position Dates: 
    Saturday, 1 October, 2016 to Saturday, 30 September, 2017
    Position: 
    SANTHE Masters Trainee, Rwanda Zambia HIV Research Group (RZHRG), Ndola, Zambia

    Sichwale is currently a laboratory scientist working on a collaborative project focussing on Intravaginal Practices (IVP) and their impact on genital tract infections in Female Sex Workers (FSW) and Single Mothers (SM) in Ndola,  Zambia.

  • Position Dates: 
    Tuesday, 1 November, 2016 to Saturday, 1 July, 2017
    Position: 
    SANTHE Masters Trainee, Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya

    Worldwide, 27 million people are estimated to be problem drug users with almost half of them being injecting drug users (IDU). A total of 1.65 million IDU are living with HIV. In Kenya, IDU is increasing especially along the coast.

  • Position Dates: 
    Friday, 1 April, 2016 to Friday, 31 March, 2017
    Position: 
    SANTHE Masters Trainee, Africa Health Research Institute (AHRI), Durban, South Africa

    The aim of Shumba’s project was to use fluorescence activated cell sorting (FACS) to isolate antibiotic survivors in Mycobacterium tuberculosis.

  • Position Dates: 
    Monday, 1 February, 2016 to Tuesday, 31 January, 2017
    Position: 
    SANTHE Intern, Botswana Harvard AIDS Institute Partnership (BHP), Gaborone, Botswana

    Phinius's first project looked at HIV's attack and depletion of CD4 T cells, hence the basis for CD4 cell counts as markers for HIV/AIDS disease progression. Antiretroviral therapy has significantly reduced CD4 T cell recovery however not significantly normalising CD4/CD8 ratio.

  • Position Dates: 
    Monday, 1 February, 2016 to Tuesday, 31 January, 2017
    Position: 
    SANTHE Intern, Botswana Harvard AIDS Institute Partnership (BHP), Gaborone, Botswana

    Moraka's study constituted a retrospective cohort study of HIV-exposed uninfected infants and their mothers which involved evaluating the effects of HIV/CMV exposure on infant adverse neurodevelopmental outcomes.

  • Position Dates: 
    Saturday, 1 October, 2016 to Friday, 9 December, 2016
    Position: 
    SANTHE Intern, Africa Health Research Institute (AHRI), Durban, South Africa

    Smithers’ project looked at the persistence of pathogens and evasion of host immune responses. His work focussed on the various immunological techniques employed in studying immune responses to HIV infection.

  • Position Dates: 
    Sunday, 1 May, 2016 to Monday, 31 October, 2016
    Position: 
    SANTHE Intern, Africa Health Research Institute (AHRI), Durban, South Africa

    Pillay and her team were interested in understanding HIV in the central nervous system. The brain is thought to be a reservoir site for HIV infection in the face of antiretroviral therapy (ART).